Literature DB >> 27044048

Establishment and Characterization of Naïve Pluripotency in Human Embryonic Stem Cells.

Sharat Warrier1, Mina Popovic1, Margot Van der Jeught1, Björn Heindryckx2.   

Abstract

Mouse embryonic stem cells are known to represent the naïve state of pluripotency, while human embryonic stem cells typically represented the primed state of pluripotency, characterized by a higher drift toward differentiation and some other disadvantages. Here we describe an efficient method for rapid, transgene free induction of the naïve pluripotent state in human by applying a novel combination of small molecules and growth factors in the culture medium (2i, LIF, basic fibroblast growth factor, ascorbic acid, and forskolin). Conversion of primed human embryonic stem cells towards the naive pluripotent state should be confirmed by a detailed characterization of the cells, as described in this chapter.

Entities:  

Keywords:  Human embryonic stem cells; Immunostaining; Karyotyping; Mouse embryonic fibroblasts; Naïve pluripotency; Quantitative real-time PCR

Mesh:

Substances:

Year:  2016        PMID: 27044048     DOI: 10.1007/7651_2016_347

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Deriving rabbit embryonic stem cells by small molecule inhibitors.

Authors:  Jiao Liu; Xiumei Zhu; Jinshan Li; Zhihui Liu; Yanhong Liu; Fei Xue; Lan Yang; Liyou An; Chien-Hong Chen; Giorgio Antonio Presicce; Qiping Zheng; Fuliang Du
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

2.  Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.

Authors:  Jeffrey Aalders; Natasja Van den Vreken; Mina Popovic; Swati Mishra; Björn Heindryckx; Jolanda van Hengel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-10-29       Impact factor: 2.416

Review 3.  Making gametes from alternate sources of stem cells: past, present and future.

Authors:  Deepa Bhartiya; Sandhya Anand; Hiren Patel; Seema Parte
Journal:  Reprod Biol Endocrinol       Date:  2017-11-16       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.